“…It is important to recognize the intricacy of known CRPS pathophysiology, however, as this may have some practical implications when considering a minimally invasive therapy like SCS that can provide efficacious treatment for several outcomes simultaneously, as compared to many other therapeutic options which carry their own treatment-specific adverse effects while targeting only one component of CRPS pathology. Identified components of CRPS pathophysiology include genetic predisposition, 28,29 minor or major trauma, [30][31][32] ischemic injury, 33,34 nitric oxide signaling, 30 neuronal injury, 30,[35][36][37] inflammatory cascade activation, [38][39][40][41][42][43][44][45][46] autoimmune antibody-mediated neuronal and vascular tissue damage, 46,48 tissue edema, 30 autonomic nervous system and adrenergic receptor perturbations, 47 motor atrophy and trophic changes, 29 sensory disturbances, 49,50 peripheral and central nervous system sensitization, 37,51-54 psychological sequelae, [55][56][57] and financial and socioeconomic implications secondary to both morbidity and disability from this syndrome. [58][59][60] Of similar complexity, a similarly diverse and multimodal array of mechanisms has been identified to underlie the effects of spinal cord stimulation.…”